NurExone Biologic Inc.: Update: NurExone Biologic Successfully Demonstrates its Patent-Pending Platform Technology for Loading Exosomes with Therapeutic Molecules

Company's analysis indicates the successful achievement of its proprietary loading technology for producing exosome-based therapies
NurExone is providing an updated release to the previously disseminated

Related Keywords

Israel ,Yosuke Ohtake ,Lior Shaltiel ,Shuxin Li ,Umar Hayat ,Twitter ,Company Or Nurexone ,Nurexone Biologic Ltd ,Youtube ,Library Of Medicine ,Nurexone Biologic Inc ,Facebook ,Israel Institute Of Technology ,Alberta Newsfile Corp ,Venture Exchange ,Tel Aviv University ,Regulation Services Provider ,Exone Biologic ,Loading Efficiency Analysis ,Visual Inspection ,Mesenchymal Stem Cells ,Flight Sheet ,Statistical Analysis ,Israel Institute ,Executive Officer ,Axon Regeneration ,Neural Repair ,Neural Regen ,Nurexone ,Biologic ,Update ,Uccessfully ,Emonstrates ,Patent ,Ending ,Platform ,Technology ,Loading ,Exosomes ,Herapeutic ,Molecules ,